Author: admin - page 32

FAMOUS Trial: Famotidine for the prevention of peptic ulcers and esophagitis in patients taking low-dose aspirin

A non-stop pharmaceutical battleā€¦ FAMOUS trial is a Phase III, randomized, double blind, placebo-controlled trial funded by the pharmaceuticals Merck and Astellas and published in 2009. In this study, Taha et al, conclude that famotidine is effective in reducing gastric and duodenal ulcers as well as erosive esophagitis in patients who require daily aspirin intake…

Read more

ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes with Alirocumab after an ACS

2018, Alirocumab after Acute Coronary Syndrome, ACC ODYSSEY Outcomes Trial Summary ODYSSEY OUTCOMES trial was a randomized, multicenter (1315 sites; 57 countries), placebo control, industry sponsored clinical trial to investigate the efficacy and safety of alirocumab (a PCSK9 inhibitor) in patients with an ACS in the preceding 1-12 months, who had inadequate control of lipids..

Read more